Oxygen Therapy Market

The latest report by IMARC Group, titled ‘Oxygen Therapy Market: Global Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2032,' offers a comprehensive analysis of the oxygen therapy market statistics. The report also includes competitor and regional analysis, along with a breakdown of segments within the industry.

The global oxygen therapy market size reached US$ 18.9 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 33.5 Billion by 2032, exhibiting a growth rate (CAGR) of 6.4% during 2024-2032.

Request a Sample Report: https://www.imarcgroup.com/oxygen-therapy-market/requestsample

Oxygen Therapy Market Overview:

Oxygen therapy is a medical treatment that involves providing additional oxygen to individuals who have difficulty obtaining enough oxygen naturally due to respiratory conditions such as COPD, asthma, pneumonia, or during surgical procedures. This therapy can be administered in various settings including hospitals, clinics, or at home, using devices like nasal cannulas, masks, or hyperbaric oxygen chambers. The oxygen used in this therapy is typically produced either through fractional distillation of liquefied air or via concentrators that filter and concentrate oxygen from ambient air. The importance of oxygen therapy lies in its ability to improve oxygen saturation in the blood, thereby enhancing tissue oxygenation and promoting better overall health outcomes in patients with compromised pulmonary function.

Oxygen Therapy Market Demand:

The global market is primarily driven by the growing need for advanced respiratory support among diverse patient populations. Additionally, the increasing incidence of respiratory diseases worldwide, coupled with a rising aging population susceptible to pulmonary conditions, is bolstering the demand for oxygen therapy. Moreover, continual technological innovations in oxygen delivery systems, such as portable and non-invasive devices, are making treatment more accessible and efficient, thus expanding the market.

Furthermore, the growing importance of oxygen therapy, leading to an increase in demand across hospitals and home care settings is driving market growth. In line with this, governments and healthcare providers are increasingly investing in healthcare infrastructure, including advanced oxygen therapy solutions, to improve clinical outcomes, thus providing an impetus to the market. Besides this, the increasing investment in research and development by medical device companies aiming to innovate and improve the effectiveness and usability of oxygen therapy equipment is stimulating the market growth.

View Full Report with TOC & List of Figure: https://www.imarcgroup.com/oxygen-therapy-market

Competitive Landscape:

The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.

• Allied Healthcare Products Inc.

• Becton Dickinson and Company

• DeVilbiss Healthcare LLC (Drive Medical Inc.)

• Fisher & Paykel Healthcare Limited

• General Electric Company

• Getinge AB

• Hersill SL

• Invacare Corporation

• Koninklijke Philips N.V

• Smiths Group plc

• Tecno-Gaz S.p.A.

• Teleflex Incorporated.

Oxygen Therapy Market Segmentation:

Our report has categorized the market based on region, product, application and end use.

Breakup by Product:

• Oxygen Source Equipment

  • Oxygen Cylinders

  • Oxygen Concentrators

  • Liquid Oxygen Devices

  • PAP Devices

• Oxygen Delivery Devices

  • Oxygen Masks

  • Nasal Cannula

  • Venturi Masks

  • Non-rebreather Masks

  • Bag Valve Masks

  • CPAP Masks

  • Others

Breakup by Application:

• Chronic Obstructive Pulmonary Disease

• Asthma

• Obstructive Sleep Apnea

• Respiratory Distress Syndrome

• Cystic Fibrosis

• Pneumonia

• Others

Breakup by End Use:

• Home Healthcare

• Hospitals

Breakup by Region:

• North America (United States, Canada)

• Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)

• Asia Pacific (China, Japan, India, Australia, Indonesia, South Korea, Others)

• Latin America (Brazil, Mexico, Argentina, Colombia, Chile, Peru, Others)

• Middle East and Africa (Turkey, Saudi Arabia, Iran, United Arab Emirates, Others)

Key Highlights of the Report:

• Market Performance (2018-2023)

• Market Outlook (2024-2032)

• Porter’s Five Forces Analysis

• Market Drivers and Success Factors

• SWOT Analysis

• Value Chain

• Comprehensive Mapping of the Competitive Landscape

About US:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic, and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact US:

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

Email: sales@imarcgroup.com

Tel No:(D) +91 120 433 0800

United States: +1-631-791-1145